Isofol Announces Initiation of a Pivotal Phase 3 Clinical Trial of arfolitixorin for the Treatment of Metastatic Colorectal Cancer 11/19/2018 Medications, GOTHENBURG, Sweden, November 15, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL)...
Phase III Trial of Darolutamide in Patients with Non-metastatic Castration-resistant Prostate Cancer Meets Primary Endpoint 11/08/2018 Medications, WHIPPANY, N.J., Oct. 24, 2018 /PRNewswire/ -- The Phase III ARAMIS (Androgen Receptor inhibiting Agent...
G1 Therapeutics Presents Additional Data from Randomized Phase 2 Trial of Trilaciclib in Combination with Etoposide/Carboplatin for Treatment of First-Line Small Cell Lung Cancer 10/23/2018 Medications, RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX),...
Epizyme Reports Positive Data on Tazemetostat in Epithelioid Sarcoma from its Phase 2 Trial Cohort at ESMO 10/23/2018 Medications, CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 22, 2018-- Epizyme, Inc. (Nasdaq: EPZM), a clinical-stage company developing novel epigenetic...
Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD 08/14/2018 Medications, LIVONIA, Mich., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage...
Vidac Pharma Announces Initiation of Phase 2b Clinical Trial of VDA-1102 Ointment in Patients with Actinic Keratosis 07/13/2018 Medications, Jerusalem, Israel, July 10 2018 – Vidac Pharma, a clinical stage oncology and dermatology focused...